open access

Vol 23, No 2 (2019)
CASE REPORT
Published online: 2019-06-12
Get Citation

Central retinal vein occlusion in hypertensive patient — a case report

Regina Pawlak, Aleksandra Krasińska, Agata Brązert, Katarzyna Piotrowska, Paweł Uruski, Andrzej Tykarski
DOI: 10.5603/AH.a2019.0010
·
Arterial Hypertension 2019;23(2):114-116.

open access

Vol 23, No 2 (2019)
CASE REPORT
Published online: 2019-06-12

Abstract

Retinal vein occlusion (RVO) is, beside diabetic retinopathy, the most common retinal vascular disease. RVO is associated
with many risk factors, both systemic and ocular. Among the systemic risk factors is hypertension. A 36-year-old man came to the hospital because of impaired vision. Central retinal vein occlusion (CRVO) was diagnosed. The main reason for developing RVO was the untreated hypertension, which was diagnosed in the form of hypertensive crisis. The patient presented numerous additional CRVO risk factors that contributed to the development of the described pathology like: obesity, dyslipidaemia, hyperhomocysteinaemia, renal cancer. The authors suggested active examination for CRVO risk factors regardless of the age of patients.

Abstract

Retinal vein occlusion (RVO) is, beside diabetic retinopathy, the most common retinal vascular disease. RVO is associated
with many risk factors, both systemic and ocular. Among the systemic risk factors is hypertension. A 36-year-old man came to the hospital because of impaired vision. Central retinal vein occlusion (CRVO) was diagnosed. The main reason for developing RVO was the untreated hypertension, which was diagnosed in the form of hypertensive crisis. The patient presented numerous additional CRVO risk factors that contributed to the development of the described pathology like: obesity, dyslipidaemia, hyperhomocysteinaemia, renal cancer. The authors suggested active examination for CRVO risk factors regardless of the age of patients.

Get Citation

Keywords

hypertension; retinal vein occlusion; risk factor

About this article
Title

Central retinal vein occlusion in hypertensive patient — a case report

Journal

Arterial Hypertension

Issue

Vol 23, No 2 (2019)

Pages

114-116

Published online

2019-06-12

DOI

10.5603/AH.a2019.0010

Bibliographic record

Arterial Hypertension 2019;23(2):114-116.

Keywords

hypertension
retinal vein occlusion
risk factor

Authors

Regina Pawlak
Aleksandra Krasińska
Agata Brązert
Katarzyna Piotrowska
Paweł Uruski
Andrzej Tykarski

References (15)
  1. Yau JWY, Lee P, Wong TY, et al. Retinal vein occlusion: an approach to diagnosis, systemic risk factors and management. Intern Med J. 2008; 38(12): 904–910.
  2. Fiebai B, Ejimadu CS, Komolafe RD. Incidence and risk factors for retinal vein occlusion at the University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria. Niger J Clin Pract. 2014; 17(4): 462–466.
  3. Kida T. Mystery of retinal vein occlusion: vasoactivity of the vein and possible involvement of endothelin-1. Biomed Res Int. 2017; 2017: 4816527.
  4. Klein R, Moss SE, Meuer SM, et al. The 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye Study. Arch Ophthalmol. 2008; 126(4): 513–518.
  5. Balogh Z, Berta A, Pfliegler G, et al. Bilateral central retinal vein occlusion caused by malignant hypertension in a young patient. Clin Exp Hypertens. 2011; 33(1): 53–55.
  6. Ponto KA, Elbaz H, Peto T, et al. Prevalence and risk factors of retinal vein occlusion: the Gutenberg Health Study. J Thromb Haemost. 2015; 13(7): 1254–1263.
  7. Giannaki K, Politou M, Rouvas A, et al. Retinal vein occlusion: genetic predisposition and systemic risk factors. Blood Coagul Fibrinolysis. 2013; 24(3): 279–283.
  8. Sivaprasad S, Amoaku WM, Hykin P, et al. RVO Guideline Group. The Royal College of Ophthalmologists Guidelines on retinal vein occlusions: executive summary. Eye (Lond). 2015; 29(12): 1633–1638.
  9. Noma H, Funatsu H, Sakata K, et al. Macular microcirculation in hypertensive patients with and without branch retinal vein occlusion. Acta Ophthalmol. 2009; 87(6): 638–642.
  10. Keilani C, Halalchi A, Wakpi Djeugue D, et al. Retinal oximetry during treatment of retinal vein occlusion by ranibizumab in patients with high blood pressure and dyslipidemia. J Fr Ophtalmol. 2016; 39(10): 816–821.
  11. Menezes VP, Cohen C, Del-Rei J, et al. Evaluation of endothelial function and arterial stiffness in obese individuals with insulin resistance. Nutr Health. 2019 [Epub ahead of print]: 260106018819374.
  12. Okura T, Miyoshi KI, Irita J, et al. Hyperhomocysteinemia is one of the risk factors associated with cerebrovascular stiffness in hypertensive patients, especially elderly males. Sci Rep. 2014; 4: 5663.
  13. Baszczuk A, Kopczyński Z, Thielemann A. [Endothelial dysfunction in patients with primary hypertension and hyperhomocysteinemia]. Postepy Hig Med Dosw (Online). 2014; 68: 91–100.
  14. Adrean SD, Schwab IR. Central retinal vein occlusion and renal cell carcinoma. Am J Ophthalmol. 2003; 136(6): 1185–1186.
  15. Tonderska M, Ciszewska J, Dróbecka-Brydak E. [Central retinal vein occlusion in the tumor of colon and kidney — difficulties in diagnosis]. Klin Oczna. 2005; 107(10–12): 700–702.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl